These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16636470)

  • 1. Enhanced hypoglycemic activity following intratracheal administration of insulin microcrystal suspension with injection adjuvant.
    Lee HK; Kwon JH; Park SH; Kim CW
    Biosci Biotechnol Biochem; 2006 Apr; 70(4):1003-5. PubMed ID: 16636470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin microcrystal suspension as a long-acting formulation for pulmonary delivery.
    Kwon JH; Lee BH; Lee JJ; Kim CW
    Eur J Pharm Sci; 2004 Jun; 22(2-3):107-16. PubMed ID: 15158896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human insulin microcrystals with lactose carriers for pulmonary delivery.
    Lim SH; Park HW; Shin CH; Kwon JH; Kim CW
    Biosci Biotechnol Biochem; 2009 Dec; 73(12):2576-82. PubMed ID: 19966492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood glucose profiles in diabetic rodents using different insulin preparations.
    Schneider S; Weber R; Luippold G
    Arzneimittelforschung; 2004; 54(12):842-6. PubMed ID: 15646368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoglycemic efficacy of pulmonary delivered insulin dry powder aerosol in rats.
    Chen XJ; Zhu JB; Wang GJ; Zhou MX; Xin FM; Zhang N; Wang CX; Xu YN
    Acta Pharmacol Sin; 2002 May; 23(5):467-70. PubMed ID: 11978199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.
    Zhang Y; Zhu J; Tang Y; Chen X; Yang Y
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1059-65. PubMed ID: 19640250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of human insulin microcrystals and their absorption enhancement by protease inhibitors in rat lungs.
    Park SH; Kwon JH; Lim SH; Park HW; Kim CW
    Int J Pharm; 2007 Jul; 339(1-2):205-12. PubMed ID: 17451895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State of insulin self-association does not affect its absorption from the pulmonary route.
    Hussain A; Ahsan F
    Eur J Pharm Sci; 2005 Jun; 25(2-3):289-98. PubMed ID: 15911225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary delivery of insulin lipid suspension].
    Jiang ZQ; Lu J
    Yao Xue Xue Bao; 2002 May; 37(5):378-82. PubMed ID: 12579846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats.
    Jo HG; Min KH; Nam TH; Na SJ; Park JH; Jeong SY
    Arch Pharm Res; 2008 Jul; 31(7):918-23. PubMed ID: 18704336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of a cocrystalline suspension of [LysB28,ProB29]-human insulin analogue.
    DeFelippis MR; Bakaysa DL; Bell MA; Heady MA; Li S; Pye S; Youngman KM; Radziuk J; Frank BH
    J Pharm Sci; 1998 Feb; 87(2):170-6. PubMed ID: 9519149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid lipid nanoparticles for pulmonary delivery of insulin.
    Liu J; Gong T; Fu H; Wang C; Wang X; Chen Q; Zhang Q; He Q; Zhang Z
    Int J Pharm; 2008 May; 356(1-2):333-44. PubMed ID: 18281169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic-pharmacodynamic modeling of subcutaneous and pulmonary insulin in rats.
    Gopalakrishnan M; Suarez S; Hickey AJ; Gobburu JV
    J Pharmacokinet Pharmacodyn; 2005 Aug; 32(3-4):485-500. PubMed ID: 16284921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice.
    Wu ZH; Ping QN; Wei Y; Lai JM
    Acta Pharmacol Sin; 2004 Jul; 25(7):966-72. PubMed ID: 15210073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats.
    Zhang Q; Shen Z; Nagai T
    Int J Pharm; 2001 May; 218(1-2):75-80. PubMed ID: 11337151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Hassanzadeh K; Mahdavi H; Koohsoltani M; Nokhodchi A
    Biopharm Drug Dispos; 2010 Mar; 31(2-3):189-201. PubMed ID: 20238376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of central administration of insulin or l-NMMA on rat skeletal muscle microvascular perfusion.
    Bradley EA; Willson KJ; Choi-Lundberg D; Clark MG; Rattigan S
    Diabetes Obes Metab; 2010 Oct; 12(10):900-8. PubMed ID: 20920043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocytes as oral delivery systems for human insulin.
    Al-Achi A; Greenwood R
    Drug Dev Ind Pharm; 1998 Jan; 24(1):67-72. PubMed ID: 15605599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical optimization of insulin-loaded Pluronic F-127 gels for buccal delivery of basal insulin.
    Das N; Madan P; Lin S
    Pharm Dev Technol; 2012; 17(3):363-74. PubMed ID: 21214425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations.
    Al-Qadi S; Grenha A; Carrión-Recio D; Seijo B; Remuñán-López C
    J Control Release; 2012 Feb; 157(3):383-90. PubMed ID: 21864592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.